Chicago, December 2, 2013 — Gamma Medica, Inc. announces new additions to its management team.
The company’s most recent hires include Jason Koshnitsky, Vice President of Sales & Marketing, and Sang Lee, Senior Director of Marketing.
Gamma Medica is expanding its sales and marketing organization to support the commercialization of the LumaGEM® Molecular Breast Imaging system (MBI).
The company also announces the launch of a newly designed.
This new online presence signifies Gamma Medica’s emergence as a newly formed company, and offers educational materials and video testimonials from medical professionals and patients.
The site is optimized for easy navigation and is designed around Gamma Medica’s new message “Providing Peace of Mind.”
“We are very excited about the launch of our new website,” said Jason Koshnitsky, Gamma Medica’s new Vice President of Sales & Marketing.
“The user friendly site welcomes patients and clinicians alike and illustrates Gamma Medica’s commitment to making LumaGEM Molecular Breast Imaging (MBI) more widely recognized and available as a diagnostic tool in the fight against breast cancer.”
About Gamma Medica, Inc.
Gamma Medica, Inc. is dedicated to the development of advanced digital imaging technologies that address the growing importance of overcoming the critical shortcomings of mammography and other screening modalities in the early detection of breast cancer.
The company designs, builds and services the LumaGEM® MBI system, the first commercially available, FDA-cleared planar, dual head, fully solid-state digital imaging system utilizing cadmium zinc telluride (CZT) technology for molecular breast imaging.